Posted on July 17, 2018

By Spyros Papapetropoulos, MD, PhD Chief Medical Officer Cavion, Inc. Collaboration with the International Essential Tremor Foundation (IETF) is critical for advancing new treatment approaches for essential tremor (ET). Our company, Cavion Inc., has been engaged in the discovery and development of a new class of T-type calcium channel (Cav3) inhibitors for the treatment of […]


Warning: Use of undefined constant php - assumed 'php' (this will throw an Error in a future version of PHP) in /home/essen608/public_html/wp-content/themes/essentialtremor2019/template-parts/content.php on line 46
Categories: Research Study